Literature DB >> 28228647

Spondyloarthropathies: Fine tuning the management of axial spondyloarthritis.

Daniel Wendling1, Clément Prati2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28228647     DOI： 10.1038/nrrheum.2017.24

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  TNFα antagonist therapy in axial spondyloarthritis: Can we do better?

Authors:  Clément Prati; Pascal Claudepierre; Philippe Goupille; Thao Pham; Daniel Wendling
Journal:  Joint Bone Spine       Date:  2016-02-10       Impact factor: 4.929

Review 2.  2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.

Authors:  Désirée van der Heijde; Sofia Ramiro; Robert Landewé; Xenofon Baraliakos; Filip Van den Bosch; Alexandre Sepriano; Andrea Regel; Adrian Ciurea; Hanne Dagfinrud; Maxime Dougados; Floris van Gaalen; Pál Géher; Irene van der Horst-Bruinsma; Robert D Inman; Merryn Jongkees; Uta Kiltz; Tore K Kvien; Pedro M Machado; Helena Marzo-Ortega; Anna Molto; Victoria Navarro-Compàn; Salih Ozgocmen; Fernando M Pimentel-Santos; John Reveille; Martin Rudwaleit; Jochen Sieper; Percival Sampaio-Barros; Dieter Wiek; Jürgen Braun
Journal:  Ann Rheum Dis       Date:  2017-01-13       Impact factor: 19.103

Review 3.  Ankylosing Spondylitis and Axial Spondyloarthritis.

Authors:  Joel D Taurog; Avneesh Chhabra; Robert A Colbert
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

4.  Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.

Authors:  Jean Wach; Marie-Claude Letroublon; Fabienne Coury; Jacques Guy Tebib
Journal:  J Rheumatol       Date:  2016-09-15       Impact factor: 4.666

5.  Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis.

Authors:  Daniel Wendling; Cédric Lukas; Julien Paccou; Pascal Claudepierre; Laurence Carton; Bernard Combe; Philippe Goupille; Francis Guillemin; Christophe Hudry; Corinne Miceli-Richard; Maxime Dougados
Journal:  Joint Bone Spine       Date:  2014-01-10       Impact factor: 4.929

6.  Should non-steroidal anti-inflammatory drugs be used continuously in ankylosing spondylitis?

Authors:  Dewi Guellec; Gaëtane Nocturne; Zuzana Tatar; Thao Pham; Jérémie Sellam; Alain Cantagrel; Alain Saraux
Journal:  Joint Bone Spine       Date:  2014-02-28       Impact factor: 4.929

7.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

Review 8.  An overview of investigational new drugs for treating ankylosing spondylitis.

Authors:  Daniel Wendling
Journal:  Expert Opin Investig Drugs       Date:  2015-11-25       Impact factor: 6.206

9.  Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

Authors:  Joachim Sieper; Désirée van der Heijde; Maxime Dougados; Philip J Mease; Walter P Maksymowych; Matthew A Brown; Vipin Arora; Aileen L Pangan
Journal:  Ann Rheum Dis       Date:  2012-07-07       Impact factor: 19.103

10.  Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.

Authors:  Josef S Smolen; Jürgen Braun; Maxime Dougados; Paul Emery; Oliver Fitzgerald; Philip Helliwell; Arthur Kavanaugh; Tore K Kvien; Robert Landewé; Thomas Luger; Philip Mease; Ignazio Olivieri; John Reveille; Christopher Ritchlin; Martin Rudwaleit; Monika Schoels; Joachim Sieper; Martinus de Wit; Xenofon Baraliakos; Neil Betteridge; Ruben Burgos-Vargas; Eduardo Collantes-Estevez; Atul Deodhar; Dirk Elewaut; Laure Gossec; Merryn Jongkees; Mara Maccarone; Kurt Redlich; Filip van den Bosch; James Cheng-Chung Wei; Kevin Winthrop; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2013-06-08       Impact factor: 19.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.